Platform commoditization risk as major EMR vendors (Epic, Oracle Health) expand native patient engagement capabilities, potentially rendering standalone solutions obsolete
Regulatory changes in healthcare reimbursement or data privacy (HIPAA, GDPR) requiring costly platform modifications or limiting functionality
Technological disruption from consumer-grade mobile solutions (patient-owned devices) replacing proprietary bedside terminals, undermining hardware revenue model
Long-term shift toward value-based care may not prioritize patient engagement ROI, limiting addressable market growth
Direct competition from well-capitalized healthcare IT giants (Epic, Oracle/Cerner, Philips, GE Healthcare) with existing hospital relationships and broader product suites
Emerging digital health startups with modern cloud-native architectures and lower-cost delivery models
Customer concentration risk if limited number of large health systems represent disproportionate revenue - loss of anchor client would be material
Difficulty differentiating in crowded patient engagement market, leading to price-based competition and margin pressure
Equity dilution risk given cash burn trajectory and potential need for additional capital raises to fund operations until profitability
Working capital strain from long hospital sales cycles and implementation timelines creating cash conversion delays
Limited financial flexibility with small market cap ($300M) and negative cash flow constraining strategic options
Foreign exchange exposure operating across USD, AUD, EUR, and Middle East currencies with Irish domicile
StructuralCompetitiveBalance Sheet
